Loading...
XSHE
002476
Market cap528mUSD
Dec 05, Last price  
6.10CNY
1D
0.49%
1Q
8.16%
Jan 2017
-41.55%
IPO
11.23%
Name

Shandong Polymer Biochemicals Co Ltd

Chart & Performance

D1W1MN
XSHE:002476 chart
P/E
66.20
P/S
6.93
EPS
0.09
Div Yield, %
0.16%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
5.26%
Revenues
539m
+39.07%
447,386,876542,753,724419,456,629515,409,798542,851,943581,184,378684,982,845667,606,686741,646,821898,010,140409,828,476449,890,702416,892,274447,314,622657,160,020592,284,770387,338,189538,663,000
Net income
56m
+977.60%
25,787,54134,681,98542,815,37156,813,20267,803,33651,248,66146,932,20547,909,79024,138,43014,829,6718,270,361091,245,92613,182,60817,948,10929,702,7805,233,31456,394,000
CFO
31m
-74.75%
18,855,46817,256,25881,795,64700169,829,43071,921,6150122,179,911145,106,40287,943,47352,747,62250,563,54932,516,43000120,964,05030,539,000
Dividend
Jun 13, 20240.01 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Shandong Polymer Biochemicals Co., Ltd., together with its subsidiaries, produces and sells oilfield chemicals in China and internationally. The company offers monomers, surfactants, and polymers. It is also involved in oil and gas engineering technology services; oil and gas exploration and development; and environmental water treatment businesses. The company was founded in 1996 and is based in Dongying, China.
IPO date
Sep 15, 2010
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT